Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBIshort: 1HP vs 3HR for Tuberculosis Infection
NCT06191692Phase 3Withdrawn
- Sponsor
- Friends for International Tuberculosis Relief
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifapentine in Tuberculosis (TB), sponsored by Friends for International Tuberculosis Relief. Planned start Nov 2024; status: withdrawn.
02
Drugs
rifapentine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06191692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06191692.